PTSD Trial, Recruiting NCT06219408 Sponsor: University of Washington Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06219408
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For clinic staff:

  • People aged 18 or older who work at or are in training at the clinic

For patients:

  • People aged 18 or older
  • People who speak English
  • People who are already a patient at the clinic where recruitment is taking place
  • People who experience pain on more than half of the days over the past 3 months
  • People whose pain is at least moderately severe and affects their daily life, based on a standard pain questionnaire score of 4 or above (confirm with trial site)
  • People who score at least 31 on a standard PTSD symptom checklist AND have experienced a recognised traumatic event — though this requirement may be adjusted during the trial if recruitment is difficult (confirm with trial site)

Who may not be able to join:

There are no exclusion criteria for clinic staff.

For patients:

  • People who are currently receiving treatment for chronic pain and/or PTSD at their clinic
  • People who have had thoughts of suicide in the two weeks before their screening appointment
  • People with severe thinking or memory difficulties that would prevent them from taking part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David Reed, PhD, University of Washington

Phone: 206-543-3752

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 February 2026
Est. completion
30 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Intervention Measure; Acceptability of Intervention Measure; Appropriateness of Intervention Measure; Participant Retainment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov